VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
🌟Lazy Sunday Lung Cancer Quiz No 5⃣:
What was the most frequent post-progression regimen after chemo+Amivantamab in MARIPOSA-2?
#some #LCSM @OncoAlert @HeSMO_X @OncoViews
@MedscapeOnc @OncologyTimes @oncologytube @EGFRmNSCLC
Oncology Conference Videos
Oncology News
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
By: Carol Fabian, MD Date. 12/07/2023 In an interview, Carol Fabian, MD, an expert in breast…
Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…
Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…
Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…
By. Saranya Chumsri, MD Date: 12/12/2023 Saranya Chumsri, MD, an expert in the field of…
By: Yara Abdou, MD, Date. 12/08/2023 At SABCS 2023, Yara Abdou, MD, a medical oncologist…
By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…